Explore the categories so you can find more about your search.

Categorie > Cholesterol

Two Merck Medicines Recommended For Approval In The European Union

Categorie : Cholesterol
Merck & Co., Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended two medicines for marketing approval in the European Union (EU). The CHMP recommended marketing approval for TREDAPTIVE? (nicotinic acid/ laropiprant, MSD) ...

read more Merck & Co., Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended two medicines for marketing approval in the European Union (EU).     The CHMP recommended marketing approval for TREDAPTIVE? (nicotinic acid/ laropiprant, MSD)  read more Thu Jun 2008 Thu Jun 2008

FDA Provides Clarity To Isis Regarding The Development Path For Mipomersen

Categorie : Cholesterol
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Genzyme Corp. (Nasdaq: GENZ) announced that the FDA has provided guidance regarding approval requirements for mipomersen. The FDA has indicated that reduction of LDL-cholesterol is an acceptable surrogate endpoint for accelerated approval of mipomersen ...

read more Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Genzyme Corp. (Nasdaq: GENZ)  announced that the FDA has provided guidance regarding approval requirements for mipomersen. The FDA has indicated that reduction of LDL-cholesterol is an acceptable surrogate endpoint for accelerated approval of mipomersen  read more Thu Jun 2008 Thu Jun 2008

Niacin's Role In Maintaining Good Cholesterol

Categorie : Cholesterol
A research team has uncovered the likely target of niacin (vitamin B3) in the liver, which should provide a clearer picture of how this vitamin helps maintain adequate HDL-cholesterol levels in the blood and thus lower the risk of heart disease.While niacin can increase plasma HDL levels, the mechan ...

read more A research team has uncovered the likely target of niacin (vitamin B3) in the liver, which should provide a clearer picture of how this vitamin helps maintain adequate HDL-cholesterol levels in the blood and thus lower the risk of heart disease.While niacin can increase plasma HDL levels, the mechan read more Thu Jun 2008 Thu Jun 2008

How Drug That Blocks Cholesterol Absorption From The Diet Works

Categorie : Cholesterol
A new study in the June issue of Cell Metabolism, a Cell Press publication, sheds light on the action of the drug ezetimibe (trade name Zetia), which is used to treat high cholesterol. Ezetimibe is unique among cholesterol-lowering drugs in that it works by cutting the amount of cholesterol taken in ...

read more A new study in the June issue of Cell Metabolism, a Cell Press publication, sheds light on the action of the drug ezetimibe (trade name Zetia), which is used to treat high cholesterol. Ezetimibe is unique among cholesterol-lowering drugs in that it works by cutting the amount of cholesterol taken in read more Thu Jun 2008 Thu Jun 2008

5 Tips To Increase HDL Cholesterol

Categorie : Cholesterol
Thanks to powerful cholesterol-lowering statin drugs, driving down low-density lipoprotein (LDL), or "bad" cholesterol, has been the primary approach to improving cholesterol levels. But there's more to the story of cholesterol and cardiovascular risk than LDL alone. Another key player is high-densi ...

read more Thanks to powerful cholesterol-lowering statin drugs, driving down low-density lipoprotein (LDL), or read more Thu Jun 2008 Thu Jun 2008

New Blood Test Reveals Risk For Metabolic Syndrome

Categorie : Cholesterol
University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing he ...

read more University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing he read more Thu Jun 2008 Thu Jun 2008

Analysis: Control Reduces Cardiovascular Risk By 42%

Categorie : Cholesterol
Results of a new analysis of the Treating to New Targets (TNT) study show that intensive low-density lipoprotein (LDL) cholesterol-lowering in patients with stable coronary heart disease (CHD) whose systolic blood pressure was less than 140 mmHg reduced the risk of major cardiovascular events, inclu ...

read more Results of a new analysis of the Treating to New Targets (TNT) study show that intensive low-density lipoprotein (LDL) cholesterol-lowering in patients with stable coronary heart disease (CHD) whose systolic blood pressure was less than 140 mmHg reduced the risk of major cardiovascular events, inclu read more Thu Jun 2008 Thu Jun 2008

Higher Cholesterol Increases Risk Of Boichemical Failure After Radical Prostatectomy

Categorie : Cholesterol
Poor cholesterol management may not only affect a man's risk for prostate cancer, but also his risk of biomedical recurrence after prostatectomy, according to new data from Duke University. ...

read more Poor cholesterol management may not only affect a man's risk for prostate cancer, but also his risk of biomedical recurrence after prostatectomy, according to new data from Duke University. read more Thu Jun 2008 Thu Jun 2008

Gene Variation May Be Responsible For Lack Of Response By Some To Cholesterol-Lowering Drugs

Categorie : Cholesterol
A variation in the way the body processes a single protein may explain why some people don't respond well to drugs that lower "bad" cholesterol, according to a report in Circulation: Journal of the American Heart Association.The gene variation, called alternative splicing, explained 9 percent of the ...

read more A variation in the way the body processes a single protein may explain why some people don't respond well to drugs that lower read more Thu Jun 2008 Thu Jun 2008

Metabolex Completes Patient Enrollment In Phase 2 Trial Of MBX-8025 For Treatment Of Dyslipidemia

Categorie : Cholesterol
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has completed enrollment in a 180-patient Phase 2 trial of MBX-8025 in overweight or obese patients with high cholesterol and ...

read more Metabolex, Inc., a  biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has completed enrollment in a 180-patient Phase 2 trial of MBX-8025 in overweight or obese patients with high cholesterol and read more Thu Jun 2008 Thu Jun 2008

Unexpected Finding Of Molecule's Dual Role In Mice May Open New Avenue To Cholesterol Reduction

Categorie : Cholesterol
Researchers have discovered an unknown regulator of fat and cholesterol production in the liver of mice, a significant finding that could lead to new therapies for lowering unhealthy blood levels of cholesterol and fats. ...

read more Researchers have discovered an unknown regulator of fat and cholesterol production in the liver of mice, a significant finding that could lead to new therapies for lowering unhealthy blood levels of cholesterol and fats. read more Thu Jun 2008 Thu Jun 2008

Incyte's Selective Oral Inhibitor Of 11beta-HSD1 Demonstrates Improvements In Insulin Sensitivity And Lowers Cholesterol Levels In Type 2 Diabetics

Categorie : Cholesterol
Incyte Corporation (Nasdaq:INCY) announced clinical results presented today at the American Diabetes Association 68th Scientific Sessions of its Phase IIa trial of INCB13739, an orally bioavailable inhibitor of the 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme. These results showed ...

read more Incyte Corporation (Nasdaq:INCY) announced clinical results presented today at the American Diabetes Association 68th Scientific Sessions of its Phase IIa trial of INCB13739, an orally bioavailable inhibitor of the 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme. These results showed read more Thu Jun 2008 Thu Jun 2008

PanGenex (PGXC) Introduces LIPIDEME? To Lower Cholesterol Naturally And Increase Cardiovascular Health

Categorie : Cholesterol
PanGenex Corporation (Pink Sheets: PGXC) announces the product launch of LIPIDEME?, an all-natural nutraceutical formulated with scientifically proven ingredients and the first product on the market to combine the triglyceride-lowering power of Omega-3 fatty acids with the cholesterol lowering abili ...

read more PanGenex Corporation (Pink Sheets: PGXC) announces the product launch of LIPIDEME?, an all-natural nutraceutical formulated with scientifically proven ingredients and the first product on the market to combine the triglyceride-lowering power of Omega-3 fatty acids with the cholesterol lowering abili read more Thu Jun 2008 Thu Jun 2008

Genes That Protect Against Atherosclerosis Identified

Categorie : Cholesterol
One way of combating atherosclerosis is to reduce levels of "bad cholesterol" in the blood. Scientists at the Swedish medical university Karolinska Institutet have now identified the genes that bring about this beneficial effect. ...

read more One way of combating atherosclerosis is to reduce levels of read more Tue Mar 2008 Tue Mar 2008

New Healthcare Marketing Vehicle Launches To Help Americans Living With Cholesterol, Diabetes And Obesity

Categorie : Cholesterol
HealthScreenDirect, a corporate wellness and direct-to-consumer health screening services company, announced today the launch of HealthPaks. This innovative cooperative advertising and marketing vehicle will feature exclusive health related products and services targeted to Americans living with hig ...

read more HealthScreenDirect, a corporate wellness and direct-to-consumer health screening services company, announced today the launch of HealthPaks. This innovative cooperative advertising and marketing vehicle will feature exclusive health related products and services targeted to Americans living with hig read more Tue Mar 2008 Tue Mar 2008

Cholesterol-Lowering Power Of Dietitian Visits

Categorie : Cholesterol
Worried about your cholesterol? You may want to schedule a few appointments with a registered dietitian, to get some sound advice about how to shape up your eating habits, according to a new national study led by University of Michigan Health System researchers.Not only are you likely to lower your ...

read more Worried about your cholesterol? You may want to schedule a few appointments with a registered dietitian, to get some sound advice about how to shape up your eating habits, according to a new national study led by University of Michigan Health System researchers.Not only are you likely to lower your  read more Wed Mar 2008 Wed Mar 2008

Pfizer Announces Plans To End Lipitor Advertising Campaign With Artificial Heart Inventor Jarvik

Categorie : Cholesterol
Pfizer on Monday announced plans to end an advertising campaign for the cholesterol medication Lipitor that features Robert Jarvik, who invented the first artificial heart, amid concerns that the ads might mislead consumers, the ...

read more Pfizer on Monday announced plans to end an advertising campaign for the cholesterol medication Lipitor that features Robert Jarvik, who invented the first artificial heart, amid concerns that the ads might mislead consumers, the  read more Wed Mar 2008 Wed Mar 2008

We Are What We Eat: Lowering Cholesterol The Old-Fashioned Way

Categorie : Cholesterol
Recent results from a small clinical trial raised confusing questions about the value of several widely used cholesterol medicines such as Zetia and its sister drug, Vytorin. The future of these drugs now depend on three large clinical trials that may show conclusively if the drugs reduce heart atta ...

read more Recent results from a small clinical trial raised confusing questions about the value of several widely used cholesterol medicines such as Zetia and its sister drug, Vytorin. The future of these drugs now depend on three large clinical trials that may show conclusively if the drugs reduce heart atta read more Wed Mar 2008 Wed Mar 2008

Abbott Receives FDA Approval For SIMCORŽ (NiaspanŽ / Simvastatin), A Novel Combination Medicine For Comprehensive Cholesterol Management

Categorie : Cholesterol
Abbott received U.S. Food and Drug Administration (FDA) approval for SIMCORŽ, the first fixed-dose combination of two widely prescribed cholesterol therapies, NiaspanŽ (Abbott's proprietary niacin extended-release) and simvastatin. ...

read more Abbott received U.S. Food and Drug Administration (FDA) approval for SIMCORŽ, the first fixed-dose combination of two widely prescribed cholesterol therapies, NiaspanŽ (Abbott's proprietary niacin extended-release) and simvastatin. read more Fri Feb 2008 Fri Feb 2008

Abbott Receives FDA Approval For SIMCOR(R) (Niaspan(R) / Simvastatin), A Novel Combination Medicine For Comprehensive Cholesterol Management

Categorie : Cholesterol
Abbott received U.S. Food and Drug Administration (FDA) approval for SIMCOR(R), the first fixed-dose combination of two widely prescribed cholesterol therapies, Niaspan(R) (Abbott's proprietary niacin extended-release) and simvastatin. ...

read more Abbott received U.S. Food and Drug Administration (FDA) approval for SIMCOR(R), the first fixed-dose combination of two widely prescribed cholesterol therapies, Niaspan(R) (Abbott's proprietary niacin extended-release) and simvastatin. read more Fri Feb 2008 Fri Feb 2008

<<< previous | 1 | 2 | 3 | 4 | 5 next >>>



     


Custom Search